1. The challenge of biosimilars;Mellstedt;Ann Oncol,2008
2. Anti-neoplastic biosimilarsthe same rules as for cytotoxic generics cannot be applied;Mellstedt;Ann Oncol,2013
3. European Medicines Agency. Guideline on Similar Biological Medicinal ProductsLondonEMA, October 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdf (20 October 2017, date last accessed).
4. What do prescribers think of biosimilars?;Aapro;Target Oncol,2012
5. Safety and efficacy of biosimilars in oncology;Schellekens;Lancet Oncol,2016